Literature DB >> 10663432

Neuroleptic-induced striatal damage in rats: a study of antioxidant treatment using accelerometric and immunocytochemical methods.

J B Lohr1, M P Caligiuri, M S Manley, J A Browning.   

Abstract

RATIONALE: Investigators have postulated that neuroleptic medications may affect the motor system through the creation of free radicals. Also, structural brain changes related to oxidative damage may disrupt normal striatal function.
OBJECTIVE: The goals of this study were to examine whether an antioxidant diet reduced the abnormal movements caused by long-term neuroleptic exposure and to examine structural effects within specific striatal regions in rats.
METHODS: Rats were given a basal diet or a diet high in antioxidants for 4 months, and treated with 10 mg/kg fluphenazine decanoate or sesame seed oil IM every 2 weeks. At baseline and after treatment, head movements were quantified by accelerometry, and immunocytochemically stained cholinergic neurons in the ventrolateral, mediodorsal, and ventromedial regions of the striatum were quantified.
RESULTS: Rats treated with fluphenazine had significantly lower neuron densities than those that did not receive antioxidants. Rats exposed to a diet consisting of antioxidants had significantly higher neuron densities than those that did not receive antioxidants in each of the three regions tested. Rats treated with fluphenazine had a greater increase in the number of accelerometric peaks recorded per minute compared with untreated animals. The increase in the number of accelerometric peaks recorded per minute was lower for animals exposed to antioxidant diets compared with unexposed animals. Lastly, there was a significant correlation between the accelerometric peak change score and cholinergic neuron density in all three regions.
CONCLUSIONS: Our results suggest that long-term neuroleptic treatment is associated with an increase in head movements and a reduction in ChAT-stained striatal cholinergic neurons and that these abnormalities are reduced by antioxidants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663432     DOI: 10.1007/s002130050039

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  4 in total

Review 1.  Oxidative mechanisms and tardive dyskinesia.

Authors:  James B Lohr; Ronald Kuczenski; Alexander B Niculescu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.

Authors:  Nicholas MacInnes; Mahmoud M Iravani; Elaine Perry; Margaret Piggott; Robert Perry; Peter Jenner; Clive Ballard
Journal:  J Neural Transm (Vienna)       Date:  2008-04-10       Impact factor: 3.575

3.  Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.

Authors:  Yuko Kataoka; Paul S A Kalanithi; Heidi Grantz; Michael L Schwartz; Clifford Saper; James F Leckman; Flora M Vaccarino
Journal:  J Comp Neurol       Date:  2010-02-01       Impact factor: 3.215

4.  Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.

Authors:  Roselei Fachinetto; Jardel G Villarinho; Caroline Wagner; Romaiana P Pereira; Robson L Puntel; Márcio W Paixão; Antonio L Braga; João Batista Calixto; João B T Rocha; Juliano Ferreira
Journal:  Psychopharmacology (Berl)       Date:  2007-07-20       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.